3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other
44
Head & Neck
21
Other hematologic neoplasm
3
Sarcoma
2
Plasma cell
2
Gastrointestinal
2
Classical hematology
2
Breast
2
Lymphoid
1
Genitourinary
1
Endocrine
1
Conditions
Anemia, Refractory, with Excess of Blasts
115
Myelodysplastic Syndromes
107
Leukemia
98
Leukemia, Myeloid, Acute
92
Anemia
70
Leukemia, Myelomonocytic, Chronic
68
Precursor Cell Lymphoblastic Leukemia-Lymphoma
67
Myeloproliferative Disorders
55
Leukemia, Lymphocytic, Chronic, B-Cell
52
Multiple Myeloma
48
Anemia, Refractory
48
Thrombocytopenia
45
Lymphoma
43
Lymphoma, Non-Hodgkin
42
Neoplasms
40
Hodgkin Disease
39
Primary Myelofibrosis
36
Leukemia, Myeloid, Chronic-Phase
36
Congenital Abnormalities
34
Anemia, Aplastic
34
Myelodysplastic-Myeloproliferative Diseases
33
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
33
Leukemia, Myeloid, Accelerated Phase
32
Lymphoma, Follicular
29
Blast Crisis
27
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
26
Burkitt Lymphoma
25
Lymphoma, Mantle-Cell
24
Neoplasms, Plasma Cell
23
Lymphoma, B-Cell, Marginal Zone
23
Interventions
Interleukin 1 Receptor Antagonist Protein
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Mucositis
×
Classical hematology
×
Clear all
NCT03233776
2024-11-18
AFFECT-1
Radboud University Medical Center
Phase 2
Completed
9 enrolled
NCT04099901
2024-11-18
AFFECT-2
Radboud University Medical Center
Phase 2
Completed
88 enrolled